What is QIPCM?
The Quantitative Imaging for Personalized Cancer Medicine (QIPCM) program provides services and tools to support multi-centre imaging studies. Support services include data de-identification and transfer, centralized storage, scanner validation and QA, imaging protocol development, novel image analysis tools development, image analysis, remote image access as well as data curation and feature extraction for large-scale imaging studies
Why use QIPCM?
Quality results from multi-centre medical imaging and radiation oncology research require consistent and robust trial protocols capable of quantifying or eliminating differences across participating institutions and solid image analysis tools. QIPCM attempts to address these issues through 3 main aims:
- Establish a stable software platform for image reads/analysis in clinical trials with capabilities for centralized image archival and remote real-time review. We provide a platform for collaboration in imaging research, including clinical trials and AI development.
- Commission a suite of defined imaging procedures and corresponding accreditation tests for use in clinical trials.
- Establish and operate a service to implement and support robust, quantitative imaging in clinical trials. We have an extensive regulatory program and quality management system to satisfy the regulatory needs of clinical trials.
How is QIPCM different?
QIPCM provides clinicians & researchers participating in multi-centre clinical trials and research studies with a central repository for large volume imaging data as well as a set of tools to provide end-to-end testing and image analysis standards of practice.
Images from each trial site are de-identified and transferred to the central repository through a secure pipeline. All data analysis is done server-side allowing the ability to perform computationally expensive operations on very large data archives remotely with minimal end-user hardware.